Feedback Share Discussion Threads

[yump] 24/1/2020 12:50

"It's gone on trial with the NHS using live patients"

I know the news has been bad but not sure what the alternative would be ?
;-)

[georgesorearse] 24/1/2020 11:51

Yes Rory as well ....

[ged5] 24/1/2020 11:27

OK, thanks. That's my understanding as well. I think it was Rory Shaw who stated it shouldn't be a problem.

[georgesorearse] 24/1/2020 10:59

It's gone on trial with the NHS using live patients, Cadran is already Ce marked and Bleepa is a derived product from Cadran - rubber stamp exercise being undertaken is my supposition.

- Tom says it himself to Andrew Scott.

[ged5] 24/1/2020 10:41

"NHS we are already CE approved via the Cadran programme, Bleepa is a small part of Cadran so comes preapproved."

George,is that supposition or have you had that confirmed by the company?

[georgesorearse] 24/1/2020 10:30

Yump - re: NHS we are already CE approved via the Cadran programme, Bleepa is a small part of Cadran so comes preapproved.

USA programmes we have remarketed ourselves as a software package supplier, the FDA changed the rules so if this is added to a USA hardware product it becomes licensed as part of the overall already approved package - same as the Fluoroscopy deal.

Tom has done a cracking job here and has been aided with the changes in the FDA approvals under Trump's administration.

The he has gone out and won the Fluoroscopy contract whilst in the middle of launching Bleepa NHS and researching and drumming up interest in Bleeper Vets.

Re the team being unproven - Rory has the qualifications and experience and Tom is showing himself to be very able, ambitious and up for the challenge.

[parsons4] 24/1/2020 07:20

yump I am still in DEMG, they are not dead but very slowly recovering. They actually made a profit this last year !!!!!!

[petekand] 23/1/2020 23:19

Pop-up constantly appearing asking me to log in. Sorted now - a year later!
Yes Ged the market appeared to show little or no enthusiasm but I thought it was a very good bit of news.
Overall, I feel the young captain is steering the good ship in a direction I feel quite comfortable at this moment.

[ged5] 23/1/2020 22:47

Good to hear you're still with us Pete. What was the problem?

I share your views about the excitement but I think the announcement of the tie up with Imaging Engineering shows a lot is happening

[petekand] 23/1/2020 18:30

Ged,
No issues with the website any longer. Someone squashed the bug a few months back.
I’m very excited with the prospects here even though it looks like nothing is happening!

[yump] 23/1/2020 18:20

I'm hoping this is not another medical product nightmare as I vowed never to buy any more shares in anything that required any sort of clinical approval and/or was to be sold into the NHS. Watched DEMG and others have a long, slow death. To be fair at least I've bought FDBK after the long slow bit...

Last time lucky I hope !

[parsons4] 23/1/2020 18:13

yump I remember now !! but I know you have issues with GB but he only referred to FDBK as them having an outstanding product. We will see !!!!

[yump] 23/1/2020 17:58

"Gerry Brandon the CEO of Integuman referred to them in a BB post."

I don't know why - it was pretty irrelevant and quite an odd reference/comparison. He should just get on with his own business.

Anyway, as long as he doesn't come near this, I'll stay invested.

[ged5] 23/1/2020 17:55

Welcome Parsons4.

I have to agree with you about the beginning of good ground-breaking growth. Still a lot of ifs and buts but the more we hear from Tom Oakley the more impressed I'm becoming.

Bleepa - new, simple, needed, recurring revenues, works with any Dicom, clinical grade images. Very promising very exciting.

Fluoroscopy (we could do with a name) - Minimal costs, gate to US markets, cost effective for customer, large growing market, if George is correct then very lucrative market, already bringing in income.

What next? I don't think Tom Oakley has finished yet. The obvious one is Bleepa for vets but don't be surprised if Cadran is applied in another field.

TexRAD - Personally I think it will be given less focus initially but too good to be forgotten.

New team - unproved but showing great initiative already.

[ducatiman] 23/1/2020 17:33

GL to you too parsons. Agreed this is an extremely informative and agreeable thread.

[parsons4] 23/1/2020 15:38

Only just invested here over the last few weeks. I heard of the company through the IQAI thread and then Gerry Brandon the CEO of Integuman referred to them in a BB post.
the information on this BB has been very detailed, hence my investment. It looks to be at the beginning of quite good ground-breaking growth. GLA

[bobd29] 23/1/2020 14:27

Oh yes Duc, that would probably warrant a rerate.

[ged5] 23/1/2020 14:27

Again I agree with most of what you're saying. Not sure about any extra Cadran growth just the recurring revenues.

The US contracts will be in the next results as you say but will the costs be before November? - maybe.

Yes, on reflection, the announcement was in January for the fluoroscopy and the software development will have taken more than 2 months. Plus Feedback have already received income from that software so a bit of good news. The major costs have been made so a bigger part of the future income will go straight to the bottom line!

I agree the veterinary field looks very exciting. The video was posted in 4446.

Here it is again, just scroll down the page:-

[georgesorearse] 23/1/2020 13:45

Ducatiman - I was agreeing with you, or at least trying to even with your best efforts to ignore that fact - its common sense, in the previous accounting period they are going to be bad as that is before the new contract and associated income was announced and received.

Prev annual income as £500k Current income £500k + a bit for extra Texrad and Cadran growth.

Fundraising £2m to spend on Future processing for Bleepa, Bleepa backroom support staff, launch costs, cost of Future processing for Image processing development or U.S contract etc etc.

If looked at alone and without any other knowledge of why I'm sure they'll look like a kamikazee pilots last flight pattern.

The fact is Bleepa is on its maiden, small scale trial - no income from that only expense until take up from NHS or Vets - look up Vivet on twitter to see Toms presentation to them in October.

The U.S.A contract is the silver lining and that wont be shown until the next accounting period - fill your boots time imo.

[ducatiman] 23/1/2020 13:34

Something like “due to recent contract awards we expect to report a maiden profit in the full year accounts” would be nice!

[ged5] 23/1/2020 13:22

I think he's agreeing with you. We are all fairly certain they will be bad.

As I posted yesterday:

The next results are from the period 1st June to 30th November 2019.

In that period we had outcome of Strategic Review, the naming of Bleepa, a leak of placing then a placing.

Bleepa at the Expo was the big event of the period followed by the announcement of the trial of Bleepa at Pennine Acute Hospitals NHS Trust.

Can't see anything there to affect the figures, so yes I agree with Ducatiman and Bob. Updates and forward looking statements are what to look out for.

Later added:

I forgot to mention in that list earlier another big event was the resignation of Alastair Riddell and Prof Rory Shaw appointed Chairman.

So there should be some good text poor figures.

[ducatiman] 23/1/2020 13:08

They follow me everywhere LR2, makes me feel important!
George, where will the revenue have been generated? We know the costs will be high! So how are they not going to be bad?

[georgesorearse] 23/1/2020 12:42

The results will not show new contract income but will show the fundraising and gearing up for Bleepa contract, so Ducatiman in that way bad ?

Will the S.P be depressed - I hope so.... I've done the research very happy to load up at these levels and if it dips, i'll add more.

[lr2] 23/1/2020 12:32

Classic. Just seen that someone has marked down your full stop Duc. :)

[ducatiman] 23/1/2020 11:20

Personally I think the results are going to be bad, so unless there is something special in the guidance the mms will Mark us down. I will have some gunpowder ready. If George’s figures are anywhere near the mark and we exceed 200 units then it’s time to top up.